CLIA, COLA, CAP-accredited clinical lab in Midwest for Sale. Unique Revenue Model, Consistent Revenue, Exceptional EBITDA Margins. Revenue: $3.4M, EBITDA: $1.4M
This almost brand new NJ Lab is set up as a high throughput lab for Molecular, Covid, and NGS testing. Revenue (10 months): $2.1M, net $1.7M, Price: $2.75M.
Profitable, fast-growing Lab in Texas. Mostly non-covid testing. Revenue / EBITDA: $5.7M/690K (2022); $8.2M/$1M+ (2023).
Fast-growing Cannabis Lab in the Northwest with high margins For Sale. EBITDA $1.7M
Fully Equipped, ISO Certified, almost new Cannabis Testing Lab in MI with State License. Save 12-18 months in setting up and 50% on the cost too. Offered for $995K.
For Sale - C1D2 certified custom-built mobile extraction lab. Hardly used. $125K.
The lab has a diversified Revenue Stream from Toxicology, Women’s Health, UTI, Covid, and Respiratory Panel Testing. The lab is well-positioned to continue to grow post-Covid. 2021 Revenue: $6.8M, EBITDA: $2.6M.